ENOB
Enochian Biosciences, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Mark R. Dybul
IPO Date
2018-02-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Enochian Biosciences, Inc.
CEO
Mark R. Dybul
IPO Date
2018-02-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 350,630 |
| $0.65 |
| 12 Sept 2023 | Sindlev Rene | director, 10 percent owner: | A-Award | Acquired | 70,126 | $0.00 |
| 1 Aug 2023 | Sindlev Rene | director, 10 percent owner: | A-Award | Acquired | 131,579 | $0.57 |
| 27 Jun 2023 | Sindlev Rene | director, 10 percent owner: | A-Award | Acquired | 1,886,794 | $0.53 |
| 27 Jun 2023 | Sindlev Rene | director, 10 percent owner: | A-Award | Acquired | 943,397 | $0.53 |
| 4 Apr 2023 | SAPIRSTEIN JAMES | director | A-Award | Acquired | 64,655 | $1.16 |
| 21 Mar 2023 | Sindlev Rene | director, 10 percent owner: | A-Award | Acquired | 877,193 | $1.14 |
| 21 Mar 2023 | Sindlev Rene | director, 10 percent owner: | A-Award | Acquired | 438,597 | $1.14 |
| 5 Jan 2023 | Alton Gregg H | director | A-Award | Acquired | 57,252 | $0.00 |